report-image

Progressive Supranuclear Palsy Treatment Market Analysis By Drug Class (Tricyclic Antidepressants, Anticholinergic Agents, Dopamine, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) & Forecast

  • PUBLISHED ON
  • 2024-10-03
  • NO OF PAGES
  • 265
  • CATEGORY
  • Healthcare & Life Sciences
Market Overview
The global progressive  supranuclear palsy treatment market size was valued at USD 15.5 million in 2021 and is projected to reach around USD 25.5 million in 2030 exhibiting a CAGR of 5.5% in the forecasted period. The rising incidences of progressive supranuclear palsy globally is projected to boost the global progressive supranuclear palsy treatment market revenue growth. Furthermore, continuous rise in per capita income of emerging country leading to optimistic effect on the whole healthcare sector, subsequently it estimated to raise the further progressive supranuclear palsy treatment market growth rate. Conversely, lack of awareness and deficiency of early discovery may constrict the market growth. Additionally, growing research and development activities by major market players for progressive supranuclear palsy treatment predicted to quicken the further market growth rate.
The incident of progressive supranuclear paralysis (PSP) is principally connected with mature age. The synapses start to hamper with age, increasing the progressions of reformist fragmentation and roasting of these cells. These cells continue to decline and offer ascent to great instances of progressive supranuclear paralysis. Subsequently, it is critical to achieve early willpower to prepared to regulate and treat the infection. The scheme made by the clinical club concerning analytic examination has given a drive to the increase of the worldwide progressive supranuclear paralysis (PSP) market. The indications of progressive supranuclear paralysis (PSP) are very direct, yet people will in overall relate them to various diseases related with mature age. This frequently stimulates delays in determination of the illness. A great many people stay under the dream of being influenced by Alzheimer's or Parkinson's infection while they have certainly changed progressive supranuclear paralysis (PSP). Consequently, the clinical business is setting resources into education and advising the majority about the obligation for appropriate analysis.

The beginning of COVID-19 has impacted financial status of numerous industry verticals across the global. The private healthcare sector is among the sectors, which has been significantly obstructed by the global pandemic. Furthermore, the pandemic has impacted growth of several businesses owing to safety measures instigated by many governments globally. The epidemic has affected the economy in three main ways, such as by creating disturbances in supply channels, by directly distressing production and demand, and through its monetary impact on healthcare markets around the world. As a result, the pandemic is anticipated to obstruct the global progressive supranuclear palsy treatment market growth during the forecasted period.

Drug Class Insights
Based on the drug class, the global progressive supranuclear palsy treatment market is bifurcated into tricyclic antidepressants, anticholinergic agents, dopamine, and others. The dopamine segment is anticipated to hold the largest share in the projected period. The factors affecting the market growth are increasing prevalence of progressive supranuclear palsy around the world. The efficient indication for the prevention and treatment of progressive supranuclear palsy.

Region Insights
North America is governing the market and is constantly developing at a huge movement recently. The existence of a constant area for neural investigation in the US and Canada has made new roads for market growth across the location. Moreover, the presence of cutting edge improvements for synapse concentrate in the district has also helped market extension.

Key Companies Insights
The market for progressive supranuclear palsy treatment is moderately competitive. With the rising applications of progressive supranuclear palsy treatment, new players are considering to enter the market. The companies are also involved in events like joint ventures, acquisitions, partnerships, mergers, and collaborations. These activities aid in growing the effect of the players in the progressive supranuclear palsy treatment market, ultimately boosting the market growth.

Some of the key companies working in the global progressive supranuclear palsy treatment market include:
• Teva Pharmaceutical Industries Ltd.
• Asceneuron Therapeutics
• Merck & Co. Inc.
• Biogen Inc.
• AbbVie Inc.
• Novartis AG
• TauRx Pharmaceuticals
• AlzProtect
• Bristol-Myers Squibb Co.
• UCB Biopharma
• Acorda Therapeutics Inc.
• Other players

Some of the Recent Developments:
• In September 2020, Alzprotect confirmed the enlistment of the first five patients to be partaken in quite a while Phase IIa clinical preliminary with its medicine applicant AZP2006 (EZEPROGIND) for reformist supranuclear paralysis (PSP) treatment.
• In July 2018, Asceneuron received orphan drug designation, for its main drug ASN120290 from the U.S. Food and Drug Administration (FDA). ASN120290’s healing potential has been confirmed in pre-clinical studies, shown for the treatment of rare neurodegenerative disease, progressive supranuclear palsy (PSP).

Segments
By Drug Class
• Tricyclic Antidepressants
• Anticholinergic Agents
• Dopamine
• Others

By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
• Latin America
o Brazil
o Argentina
o Colombia
• MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process




We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).

Solution

The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.


Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


Conclusion

The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.


CHOOSE LICENSE TYPE
QLOUD
Pricing

Select a license type that suits your business needs

Single User Access

US $3499

Only Three Thousand Four Hundred Ninety Nine US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4499

Only Four Thousand Four Hundred Ninety Nine US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5499

Only Five Thousand Four Hundred Ninety Nine US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI